Literature DB >> 443244

Influenza A and B virus infection in infants and young children during the years 1957-1976.

H W Kim, C D Brandt, J O Arrobio, B Murphy, R M Chanock, R H Parrott.   

Abstract

Influenza A virus activity was demonstrated in infants and young children from metropolitan Washington, DC during each of 19 successive August-July respiratory disease years, and during 17 of these years at least 2% of hospitalized respiratory disease patients yielded an influenza A or B virus and/or showed an influenza A or B serum complement-fixing (CF) antibody response. Between October 1957 and July 1976, 14.3% of 860 croup patients and 5.3% of a total of 5655 hospitalized respiratory patients, including croup patients, showed evidence of influenza A or B infection. The mean period of hospitalization with either virus was about 8 days, though serious infection with influenza A virus was 4.5 times more common than with influenza B virus. Both influenza viruses were detected more frequently in respiratory disease outpatients than in respiratory disease inpatients. Patients with serious influenza A virus infections were especially likely to have croup (particularly during the H3N2 era), to be seen during December through February, and to be black male infants. During the peak month of a composite of 13 consecutive influenza A virus outbreaks, influenza A virus infection was demonstrated in 67.6% of croup patients and in 35.6% of all hospitalized respiratory patients including croup patients. During the peak month of a composite of 6 consecutive influenza B virus outbreaks, influenza B virus infection was demonstrated in 36.0% of croup patients and in 10.8% of all hospitalized respiratory disease patients including croup patients.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 443244     DOI: 10.1093/oxfordjournals.aje.a112704

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  35 in total

Review 1.  Current research on respiratory viral infections: Third International Symposium.

Authors:  A C Schmidt; R B Couch; G J Galasso; F G Hayden; J Mills; B R Murphy; R M Chanock
Journal:  Antiviral Res       Date:  2001-06       Impact factor: 5.970

2.  Surveillance of respiratory viral infections by rapid immunofluorescence diagnosis, with emphasis on virus interference.

Authors:  G Anestad
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

3.  Impact of maternal immunization on influenza hospitalizations in infants.

Authors:  Katherine A Poehling; Peter G Szilagyi; Mary A Staat; Beverly M Snively; Daniel C Payne; Carolyn B Bridges; Susan Y Chu; Laney S Light; Mila M Prill; Lyn Finelli; Marie R Griffin; Kathryn M Edwards
Journal:  Am J Obstet Gynecol       Date:  2011-02-23       Impact factor: 8.661

4.  Limited compatibility of polymerase subunit interactions in influenza A and B viruses.

Authors:  Kerstin Wunderlich; Mindaugas Juozapaitis; Benjamin Mänz; Daniel Mayer; Veronika Götz; Andrea Zöhner; Thorsten Wolff; Martin Schwemmle; Arnold Martin
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

5.  Production of passive immunity in neonatal ferrets following maternal vaccination with killed influenza A virus vaccines.

Authors:  C Sweet; R A Bird; K Jakeman; D M Coates; H Smith
Journal:  Immunology       Date:  1987-01       Impact factor: 7.397

6.  Influenza-related hospitalization and ED visits in children less than 5 years: 2000-2011.

Authors:  Astride Jules; Carlos G Grijalva; Yuwei Zhu; H Keipp Talbot; John V Williams; Katherine A Poehling; Sandra S Chaves; Kathryn M Edwards; William Schaffner; David K Shay; Marie R Griffin
Journal:  Pediatrics       Date:  2014-12-08       Impact factor: 7.124

7.  Effects of social and family factors on viral respiratory infection and illness in the first year of life.

Authors:  G Gardner; A L Frank; L H Taber
Journal:  J Epidemiol Community Health       Date:  1984-03       Impact factor: 3.710

8.  Use of PCR-enzyme immunoassay for identification of influenza A virus matrix RNA in clinical samples negative for cultivable virus.

Authors:  T Cherian; L Bobo; M C Steinhoff; R A Karron; R H Yolken
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

9.  Fifty Years of Influenza A(H3N2) Following the Pandemic of 1968.

Authors:  Barbara J Jester; Timothy M Uyeki; Daniel B Jernigan
Journal:  Am J Public Health       Date:  2020-05       Impact factor: 9.308

10.  Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.

Authors:  Kerstin Wunderlich; Daniel Mayer; Charlene Ranadheera; Anne-Sophie Holler; Benjamin Mänz; Arnold Martin; Geoffrey Chase; Werner Tegge; Ronald Frank; Ulrich Kessler; Martin Schwemmle
Journal:  PLoS One       Date:  2009-10-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.